Please Wait
Applying Filters...
menu
    • menu
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Ustekinumab

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 18Stelara

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Stelara

    Ustekinumab

    arrow
    ASPEN
    Not Confirmed

    Brand Name : Stelara

    U.S.A
    arrow
    ASPEN
    Not Confirmed

    Johnson & Johnson

    Ustekinumab

    Main Therapeutic Indication : Immunology

    Currency : USD

    2020 Revenue in Millions : 7,707

    2019 Revenue in Millions : 6,361

    Growth (%) : 21

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Stelara

    Ustekinumab

    arrow
    ASPEN
    Not Confirmed

    Brand Name : Stelara

    Japan
    arrow
    ASPEN
    Not Confirmed

    Mitsubishi Tanabe

    Ustekinumab

    Main Therapeutic Indication : Immunology

    Currency : USD

    2020 Revenue in Millions : 265

    2019 Revenue in Millions : 230

    Growth (%) : 15

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Stelara

    Ustekinumab

    arrow
    ASPEN
    Not Confirmed

    Brand Name : Stelara

    Japan
    arrow
    ASPEN
    Not Confirmed

    Mitsubishi Tanabe

    Ustekinumab

    Main Therapeutic Indication : Immunology

    Currency : USD

    2021 Revenue in Millions : 406

    2020 Revenue in Millions : 262

    Growth (%) : 67

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Stelara

    Ustekinumab

    arrow
    ASPEN
    Not Confirmed

    Brand Name : Stelara

    U.S.A
    arrow
    ASPEN
    Not Confirmed

    Johnson & Johnson

    Ustekinumab

    Main Therapeutic Indication : Immunology

    Currency : USD

    2021 Revenue in Millions : 9,134

    2020 Revenue in Millions : 7,707

    Growth (%) : 19

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Stelara

    Ustekinumab

    arrow
    ASPEN
    Not Confirmed

    Brand Name : Stelara

    Japan
    arrow
    ASPEN
    Not Confirmed

    Mitsubishi Tanabe

    Ustekinumab

    Main Therapeutic Indication : Immunology

    Currency : USD

    2022 Revenue in Millions : 500

    2021 Revenue in Millions : 435

    Growth (%) : 15

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Stelara

    Ustekinumab

    arrow
    ASPEN
    Not Confirmed

    Brand Name : Stelara

    U.S.A
    arrow
    ASPEN
    Not Confirmed

    Johnson & Johnson

    Ustekinumab

    Main Therapeutic Indication : Immunology

    Currency : USD

    2022 Revenue in Millions : 9,723

    2021 Revenue in Millions : 9,134

    Growth (%) : 6

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Stelara

    Ustekinumab

    arrow
    ASPEN
    Not Confirmed

    Brand Name : Stelara

    U.S.A
    arrow
    ASPEN
    Not Confirmed

    Johnson & Johnson

    Ustekinumab

    Main Therapeutic Indication : Immunology

    Currency : USD

    2023 Revenue in Millions : 10,858

    2022 Revenue in Millions : 9,723

    Growth (%) : 12

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Stelara

    Ustekinumab

    arrow
    ASPEN
    Not Confirmed

    Brand Name : Stelara

    Japan
    arrow
    ASPEN
    Not Confirmed

    Mitsubishi Tanabe

    Ustekinumab

    Main Therapeutic Indication : Immunology

    Currency : USD

    2023 Revenue in Millions : 439

    2022 Revenue in Millions : 500

    Growth (%) : -1

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Brand Name : Stelara

    Ustekinumab

    arrow
    ASPEN
    Not Confirmed

    Brand Name : Stelara

    U.S.A
    arrow
    ASPEN
    Not Confirmed

    Johnson & Johnson

    Ustekinumab

    Main Therapeutic Indication : Immunology

    Currency : USD

    2024 Revenue in Millions : 10,361

    2023 Revenue in Millions : 10,858

    Growth (%) : -5

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Brand Name : Stelara

    Ustekinumab

    arrow
    ASPEN
    Not Confirmed

    Brand Name : Stelara

    Japan
    arrow
    ASPEN
    Not Confirmed

    Mitsubishi Tanabe

    Ustekinumab

    Main Therapeutic Indication : Immunology

    Currency : USD

    2024 Revenue in Millions : 389

    2023 Revenue in Millions : 437

    Growth (%) : -11

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.